S100B vs. "GFAP and UCH-L1" assays in the management of mTBI patients.

Charlotte OrisJean-Baptiste Bouillon-MinoisSamy KahouadjiBruno PereiraGabriel DhaibyValentin Bailly DefranceJulie DurifJeannot SchmidtFarès MoustafaDamien BouvierVincent Sapin

Published in: Clinical chemistry and laboratory medicine (2023)

We highlight the usefulness of measuring plasma "GFAP and UCH-L1" levels to target mTBI patients (sampling within 12 h post-injury) and optimize the reduction of CT scans.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
computed tomography
peritoneal dialysis
prognostic factors
magnetic resonance imaging
patient reported outcomes
positron emission tomography
mild traumatic brain injury